Skip to main content
Caplight Logo









IRCEM Prévoyance

IRCEM Prévoyance

Roubaixircem.eu

Overview

IRCEM Prévoyance is a French provident institution, part of the social protection group Groupe IRCEM, that also makes direct investments in companies, notably in the biotechnology and social impact sectors.

Year Founded

1994

Portfolio Companies

1

Website

ircem.eu

Investments

IRCEM Prévoyance investments
CompanyDateStageLead
PeptinovMay 2023Venture - Series UnknownCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is IRCEM Prévoyance based?

IRCEM Prévoyance is headquartered in Roubaix, France.

When was IRCEM Prévoyance founded?

IRCEM Prévoyance was founded in 1994.

How many portfolio companies does IRCEM Prévoyance have?

IRCEM Prévoyance has 1 portfolio company in Caplight's dataset.

What are some companies in IRCEM Prévoyance's portfolio?

Portfolio companies visible on Caplight include Peptinov.

What was IRCEM Prévoyance's most recent investment shown here?

IRCEM Prévoyance's most recent investment in this portfolio sample was in Peptinov in 2023.

What sectors does IRCEM Prévoyance focus on?

IRCEM Prévoyance focuses on Healthcare & Life Sciences.

What company stages does IRCEM Prévoyance focus on?

Stage focus information for IRCEM Prévoyance is not publicly available.

Firmographic Details

HeadquartersRoubaix
Year Founded1994

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?